BD311 / BDgene 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BD311 / BDgene
NCT05099094: VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Recruiting
1
18
RoW
BD311
Shanghai BDgene Co., Ltd., Eye & ENT Hospital of Fudan University
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
09/23
09/23

Download Options